An interventional study of Electromyostimulation (EMS) and Myoton in Muscle Atrophy, Myotonia and Stiffness; Spine, sponsored by Charite University, Berlin, Germany. Enrolling by invitation at 1 site in Germany. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-23.
Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Muscular Atrophy with a site in Germany — 7 open to participants now, 8 under way, 1 of them phase 3. Muscular Atrophy · Germany.
Among the 23 studies in Muscular Atrophy with a site in Germany, this one is the 18th largest by planned enrollment of the 21 interventional ones that give a count, is the only one that started in 2025, is one of 16 with no phase, and was the 18th registered.
413 studies on the registry are indexed under Muscular Atrophy; 76 are open to participants now.
Browse Muscular Atrophy studies →7 of the 23 studies in Muscular Atrophy with a site in Germany are open now. Recruiting first, the newest first:
University of Erlangen-Nürnberg Medical School · Sites in Germany
Ages 18+
Universitätsklinikum Hamburg-Eppendorf · Sites in Germany
Ages 18+ · Women only
University Hospital of Cologne · Sites in Germany
Ages 18+
Medical University of Vienna · Sites in Germany, Austria, Italy
Ages 18+
Technical University of Munich · Sites in Germany, Austria
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 51 Muscular Atrophy studies recruiting now, 25 (49%) set no upper age limit and 13 (25%) stop at 75 or younger; 4 take children under 18; 16 take healthy volunteers.
This study: 40 Years to 60 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 12 is below the median of 40 across 327 interventional studies indexed under Muscular Atrophy.
Median enrollment 130 across the 21 interventional studies, 472 across the 2 observational. Of the 12 that completed or were terminated, 2 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 23 have an industry lead sponsor. The 10 most frequent:
Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.
Charite University, Berlin, Germany has 1 study filed under Muscular Atrophy — fewer than ten, so there is no comparison to draw.
1 of the studies in Muscular Atrophy with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05919940Technical University of MunichImproved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies in Muscular Atrophy with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a prospective spaceflight study involving an investigational non-risk device called the EasyMotionSkin for whole body electric muscle (myo) stimulation (WB-EMS) onboard the International Space Station (ISS).
The purpose of this study is to show:
Eight (n=8) astronauts on long duration missions will take part in this study. This experiment uses the following hardware/software (HW \& SW): (A) EasymotionSkin suit (dry electrode muscle stimulation), B) non-invasive hand-held Myoton device (digitized passive muscle stiffness data collection). C) a customized Myoton body template suit (elastic yoga suit with customized anatomical reference labels to aid inflight Myoton data collection on dedicated perforated 2x2 cm small skin fields) at 5 different skin measurement points (MP), neck, back, shoulder, legs.
Before and after flight the following tests will be done once: Myoton data collection, dynamometry strength test, magnetic resonance imaging (MRI) for baseline comparison. Researchers will compare data from a non EMS control group (non EMS Astronauts, retrospective) to see if changes of passive muscle stiffness is seen in EMS Astronauts before, during and after spaceflight
In a previous space analog study (60 days reactive jumps on a sledge during bed rest immobilisation, Cologne, Germany, 2015) on n=24 voluntary participants followed by an experiment on the International Space Station, ISS (MYOTONES 2015-2023) the investigators used non-invasive Myoton technology (Myoton device) to detect digital biomarkers (passive muscle tone and stiffness) on twelve (n=12) study participants together with clinical imaging (MRI), muscle strength tests (dynamometry), and blood samples (biosamples) to study muscle properties and adaptation in microgravity following routine inflight exercise in ISS Astronauts. One of the MYOTONES ISS Astronaut already tested a space-qualified EasymotionSkin suit (Demo-Tech Experiment, German Aerospace Agency, Deutsches Zentrum fuer Luft- und Raumfahrt, DLR, 2022) that was used for about 20 minutes on top of the daily routine exercise protocol in order to optimize inflight training outcome by EMS technology in spaceflight. Preliminary results (n=1) showed feasibility of the novel EMS technology in spaceflight and suggested improved muscle health parameters (increased tone and stiffness) found in some muscle from torso (lower back) and limbs compared to a non-EMS mission crewmember. Easymotion-2 is designed to replicate similar changes in inflight passive muscle parameters (resembling muscle health) in eight (n=8) more ISS Astronauts for robust statistical analyses and interpretation. Pre and postflight baseline data collections with Myoton technology (passive tone [Hz] and stiffness [N/m]) serve as control for comparison. Protocol and recruitment of healthy study participants (male or female Astronauts) is under control by NASA via Informed Consent Briefing standardized procedures.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Astronauts with active Flight Medical
Exclusion Criteria:
Healthy Astronauts that perform EMS-assisted inflight exercise onboard the International Space Station
Device: Electromyostimulation (EMS) · Device: Myoton · Diagnostic Test: Electromyography (EMG) · Diagnostic Test: Magnetic Resonance Imaging (MRI) · Diagnostic Test: Dynamometry
EasymotionSkin body suit for digitally controlled electric impulses via Easymotion-2 software on crew iPad (frequency, impulse rate, duration) are transferred from integrated dry electrodes of the EMS- stimulation suit to activate surface muscle groups of the body (trunk), arms and legs
Also known as: EMS body muscle stimulation
The non-invasive Myoton technology collects data from passive muscle properties (tone and stiffness) obtained from selected anatomical surface muscle groups
Also known as: passive muscle properties
As a standard method, surface EMG collects data from nerve impulse-triggered active muscle contractions, pre/postflight only
Also known as: surface EMG/nerve impulse rate [amplitude/frequency]
MRI is a clinically standard (non-radiation) imaging method to study structural changes of the human body (organs, muscle, bones, tendons) at the macroscopic level, pre/postflight only
Also known as: MRI, Magnetic Resonance Tomography
Dynamometry is a standard functional and diagnostic method to test muscle strength in sports and rehabilitation. pre/postflight only
Also known as: muscle functional test
Myoton Tone (baseline preflight)
Passive muscle tone \[Hz\] numerical indices. Abbreviations for Outcome Measures 1-37: Hertz, Hz; Newton/meter, N/m; before launch (preflight), L-; recovery (postflight), R+; inflight days, FD; not earlier than, NET; not later than, NLT; electro-myo-stimulation, EMS; versus/against, vs; surface electromyography, sEMG.
Time frame: L-105+/-30 days (time window)
Myoton Tone (recovery postflight)
Passive muscle tone \[Hz\] numerical indices. Abbreviations for Outcome Measures 1-37: Hertz, Hz; Newton/meter, N/m; before launch (preflight), L-; recovery (postflight), R+; inflight days, FD; not earlier than, NET; not later than, NLT; electromyostimulation, EMS; versus/against, vs; surface electromyography, sEMG.
Time frame: R+30+/-10 days (time window)
Myoton Tone (inflight, preEMS-1)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
Time frame: FD20-30 days (time window)
Myoton Tone (inflight, preEMS-2)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
Time frame: FD60-80 days (time window)
Myoton Tone (inflight, post EMS-1)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
Time frame: NET R-18 days (time window)
Myoton Tone (inflight, post EMS-2)
Passive muscle tone \[Hz\] numerical indices. Abbreviations: see Outcome1
Time frame: NLT R-12 days (time window)
Myoton stiffness (baseline, preflight).
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
Time frame: L-105+/-30 days (time window)
Myoton stiffness (recovery, postflight).
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
Time frame: R+30+/-10 days (time window)
Myoton stiffness (inflight, preEMS-1)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
Time frame: FD20-30 days (time window)
Myoton stiffness (inflight, preEMS-2)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
Time frame: FD60-80 days (time window)
Myoton stiffness (inflight, postEMS-1)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
Time frame: NET R-18 days (time window)
Myoton stiffness (inflight, postEMS-2)
Passive muscle stiffness \[N/m\] numerical indices. Abbreviations: see Outcome 1
Time frame: NLT R-12 days (time window)
EMS body stimulation (inflight EMS1)
1st out of a total of 12 (1/12) single EMS-assisted inflight exercise between NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24. Abbreviations: see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS2)
2/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS3)
3/12 single EMS-assisted inflight exercise, NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days(time window)
EMS body stimulation (inflight EMS4)
4/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS5)
5/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS6)
6/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS7)
7/12 single EMS-assisted inflight exercise, NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out")at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS8)
8/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS9)
9/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS10)
10/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS11)
11/12 single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
EMS body stimulation (inflight EMS12)
Last out of a total of twelve (12/12) single EMS-assisted inflight exercise NET R-60 and NLT R-21 days (time window) with 1-4 days in between "wash-out") at tolerable stimulation merged to nominal daily inflight exercise countermeasure sessions at crew discretion. Applies to Outcome Measures 13-24: Abbreviations see Outcome 1.
Time frame: NET R-60 and NLT R-21 days (time window)
Dynamometry (baseline, preflight/power).
Standard muscle isometric/isokinetic tests (power \[Watt\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
Time frame: L-105+/-30 days (time window)
Dynamometry (baseline, preflight/torque).
Standard muscle isometric/isokinetic tests ( torque \[Nm\]) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
Time frame: L-105+/-30 days (time window)
sEMG (baseline, preflight/amplitude).
Non-invasive sEMG by amplitude on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
Time frame: L-105+/-30 days (time window)
sEMG (baseline, preflight/frequency).
Non-invasive sEMG by frequency (Hz) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
Time frame: L-105+/-30 days (time window)
Dynamometry (recovery postflight/power).
Standard muscle isometric/isokinetic tests (power \[Watt\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
Time frame: R+30+/-10 days (time window)
Dynamometry (recovery postflight/torque).
Standard muscle isometric/isokinetic tests (torque \[Nm\] on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus). Abbreviations: see Outcome 1
Time frame: R+30+/-10 days (time window)
sEMG (recovery postflight/amplitude).
Non-invasive surface EMG (amplitude) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
Time frame: R+30+/-10 days (time window)
sEMG (recovery postflight/frequency).
Non-invasive surface EMG (Hz) on calf muscle (gastrocnemius) and lower deep back muscle (erector spinae/multifidus) as part of dynamometry. Abbreviations: see Outcome 1
Time frame: R+30+/-10 days (time window)
Magnetic Resonance Imaging (MRI) (baseline preflight).
Standard clinical structural analysis by optical sections of lower leg and lumbar back muscle profile/volume area (square/3-D, centimeters). Abbreviations: see Outcome 1
Time frame: L-105+/-30 days (time window)
Magnetic Resonance Imaging (MRI) (recovery postflight).
Standard clinical structural analysis by optical sections of lower leg and lumbar back muscle profile/volume area (square/3-D, centimeters). Abbreviations: see Outcome 1
Time frame: R+30+/-10 days (time window)
EMS protocol report (ms)
Multiple measurements (milliseconds=ms) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. see Outcome1
Time frame: NET R-60 and NLT R-21 days (time window)
EMS protocol report (minutes)
Multiple measurements (duration/min.) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. Abbreviations: see Outcome1
Time frame: NET R-60 and NLT R-21 days (time window)
EMS protocol report (Hz)
Multiple measurements (frequency/Hz) will be aggregated for each of the 12 single inflight EMS session (see Outcome 13-24) to report on inflight EMS protocol and to collect technical data (of muscle stimulation) for whole body inflight EMS monitoring and assessment. Abbreviations: see Outcome1
Time frame: NET R-60 and NLT R-21 days (time window)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Results will not be shared to other researchers due to privacy reasons of participating Astronauts related to their Space Agencies
Started Sep 2025 (actual). Primary completion is estimated for Jul 2029, 46 months after the start.
Of 170 non-industry interventional studies with no phase under Muscular Atrophy, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 38. This study's planned 46 months is above that.
Counting every sponsor, half of 176 studies reached it within 21 months; a quarter within 9 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →